Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan [Phase 2, Phase 3]
This update summarizes the completed long-term safety study of alogliptin in combination with a thiazolidinedione in Japanese participants w…
-
CLINICAL_TRIALS trial_result · 2011-08-31Clinical Trial Update: Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride [Phase 3]
Phase 3 randomized trial comparing HOE490 O (glimepiride/metformin) versus placebo as an add-on to ongoing glimepiride therapy in adults wit…
-
CLINICAL_TRIALS other · 2011-08-31Clinical Trial Update: The Swiss Glucose Variability Study [Phase 4]
Phase 4 clinical trial update from the University of Zurich on glucose variability in Type 2 diabetes; no results or current status are prov…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: Comparison of Soy-milk and Cow Milk Consumption on Inflammatory Factors, Cardiovascular Factors ,Renal Factors, Fibrinolytic Indice and Oxidative Stress Among Type-2 Diabetic Patients With Nephropathy Stage 1 and 2 [Phase 3]
A Phase 3 completed trial comparing soy milk versus cow milk on inflammatory, cardiovascular, renal factors, fibrinolytic indices, and oxida…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR) [Phase 2]
A Phase 2 trial ARMOR evaluating renal mechanisms of creatinine excretion in patients with Type 2 diabetes treated with tesaglitazar has bee…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes. [Phase 2]
A Phase 2 safety and efficacy study evaluating alogliptin for glycemic control in adults with Type 2 diabetes has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating the efficacy and safety of alogliptin in adults with Type 2 diabetes; results were posted after completion of the s…
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan [Phase 2, Phase 3]
A long-term safety study (Phase 2/3) evaluated alogliptin used in combination with an α-glucosidase inhibitor in Japanese participants with …
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe [NA]
A completed clinical trial comparing high-dose simvastatin alone to combination therapy with ezetimibe, examining effects on NF-κB activity …
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: The Effect of Leucine on Body Composition and Muscle Characteristics in Elderly, Type 2 Diabetes Patients [Phase 2, Phase 3]
This update summarizes the results of a Phase 2/Phase 3 trial evaluating leucine supplementation on body composition and muscle characterist…
-
CLINICAL_TRIALS trial_result · 2011-08-25Clinical Trial Update: Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial evaluating the efficacy and safety of combining alogliptin with metformin in adults with type 2 diabetes mellitus; results wer…
-
FDA approval · 2011-08-25FDA Approved: GLYBURIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved Heritage Pharmaceuticals' supplemental application for glyburide (GLYBURIDE) from Heritage Pharmaceuticals Inc. d/b/a Avet Phar…
-
CLINICAL_TRIALS trial_result · 2011-08-25Clinical Trial Update: Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus. [Phase 3]
Phase 3 trial evaluating alogliptin in combination with a sulfonylurea for Type 2 diabetes mellitus has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2011-08-25Clinical Trial Update: Effects of Different Types of Exercise in Type 2 Diabetes [NA]
A completed clinical trial evaluating the effects of different types of exercise on people with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS withdrawal · 2011-08-25Clinical Trial Update: A Study in Patients With Type 2 Diabetes [Phase 2]
A Phase 2 clinical trial conducted by Eli Lilly in patients with Type 2 diabetes mellitus has been withdrawn.
-
FDA approval · 2011-08-18FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for the generic drug glyburide under ANDA074686.
-
CLINICAL_TRIALS trial_result · 2011-08-17Clinical Trial Update: A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy [Phase 2]
Phase 2 trial comparing multiple doses of SK-0403 to placebo and sitagliptin 100 mg in adults with type 2 diabetes not well controlled on me…
-
CLINICAL_TRIALS research · 2011-08-17Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes [Phase 1]
Phase 1 safety, tolerability, and pharmacokinetics study of EGT0001474 in subjects with type 2 diabetes has been completed with results post…
-
CLINICAL_TRIALS trial_result · 2011-08-16Clinical Trial Update: Observational Study to Evaluate the Safety of Levemir® in Diabetes
An observational safety study evaluating Levemir (insulin detemir) in people with diabetes has completed, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-08-15Clinical Trial Update: Drug-drug Interaction Study(CKD-501, Amlodipine) [Phase 1]
Phase 1 drug-drug interaction study of CKD-501 with amlodipine has completed.
-
EMA withdrawal · 2011-08-12EMA Withdrawn: Avaglim (rosiglitazone;glimepiride) — SmithKline Beecham Ltd
Avaglim (rosiglitazone; glimepiride) has been withdrawn from the market.
-
CLINICAL_TRIALS trial_result · 2011-08-12Clinical Trial Update: Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes. [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of combining alogliptin with insulin in Type 2 diabetes; the study completed and results w…
-
CLINICAL_TRIALS trial_result · 2011-08-12Clinical Trial Update: Multifactorial Intervention in Type 2 Diabetes - Italy [Phase 4]
A Phase 4 clinical trial in Italy evaluates a multifactorial intervention for Type 2 diabetes mellitus, with current status listed as UNKNOW…
-
CLINICAL_TRIALS trial_result · 2011-08-11Clinical Trial Update: Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes [Phase 2]
A Phase 2 study evaluating the efficacy and safety of MCI-196 in patients with Type 2 diabetes has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2011-08-11Clinical Trial Update: Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications
A completed trial evaluates the SCOUT noninvasive AGE measurement method for predicting diabetes-related complications in individuals with t…